HASELTINE, ERIC L.,MOSKOWITZ, SAMUEL,ROBERTSON, SARAH,WALTZ, DAVID
申请号：
CA3069225
公开号：
CA3069225A1
申请日:
2018.07.17
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Methods of treating cystic fibrosis comprising administering at least Compound (I) of the formula. Pharmaceutical compositions containing a pharmaceutically acceptable salt of at least Compound I and methods of treating cystic fibrosis comprising administering a pharmaceutically acceptable salt of at least Compound (I).
